TTX-MC138
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TTX-MC138, covering 2025-10-02 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of TTX-MC138 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]